- Home
- EVGN vs TLPH Comparison
EVGN vs TLPH Comparison
Compare EVGN & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- TLPH
- Stock Information
- Founded
- EVGN 1999
- TLPH 2005
- Country
- EVGN Israel
- TLPH United States
- Employees
- EVGN N/A
- TLPH N/A
- Industry
- EVGN Agricultural Chemicals
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- EVGN Industrials
- TLPH Health Care
- Exchange
- EVGN Nasdaq
- TLPH Nasdaq
- Market Cap
- EVGN 11.3M
- TLPH 10.6M
- IPO Year
- EVGN N/A
- TLPH 2011
- Fundamental
- Price
- EVGN $1.34
- TLPH $0.42
- Analyst Decision
- EVGN Strong Buy
- TLPH Strong Buy
- Analyst Count
- EVGN 1
- TLPH 1
- Target Price
- EVGN $3.50
- TLPH $6.00
- AVG Volume (30 Days)
- EVGN 136.9K
- TLPH 875.4K
- Earning Date
- EVGN 08-21-2025
- TLPH 08-13-2025
- Dividend Yield
- EVGN N/A
- TLPH N/A
- EPS Growth
- EVGN N/A
- TLPH N/A
- EPS
- EVGN N/A
- TLPH N/A
- Revenue
- EVGN $6,765,000.00
- TLPH $27,000.00
- Revenue This Year
- EVGN N/A
- TLPH N/A
- Revenue Next Year
- EVGN $113.18
- TLPH $14,533.26
- P/E Ratio
- EVGN N/A
- TLPH N/A
- Revenue Growth
- EVGN N/A
- TLPH N/A
- 52 Week Low
- EVGN $0.95
- TLPH $0.38
- 52 Week High
- EVGN $6.30
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- EVGN 50.47
- TLPH 36.74
- Support Level
- EVGN $1.32
- TLPH $0.38
- Resistance Level
- EVGN $1.50
- TLPH $0.79
- Average True Range (ATR)
- EVGN 0.08
- TLPH 0.06
- MACD
- EVGN -0.01
- TLPH -0.00
- Stochastic Oscillator
- EVGN 42.77
- TLPH 9.76
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.